Diazepam - PubMed (original) (raw)

Book

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan.

2023 Aug 28.

Affiliations

Free Books & Documents

Book

Diazepam

Jaberpreet S. Dhaliwal et al.

Free Books & Documents

Excerpt

Diazepam is a benzodiazepine medication that is FDA approved for the management of anxiety disorders, short-term relief of anxiety symptoms, spasticity associated with upper motor neuron disorders, adjunct therapy for muscle spasms, preoperative anxiety relief, management of certain refractory epilepsy patients, and adjunct in severe recurrent convulsive seizures, and an adjunct in status epilepticus. Off-label (non-FDA approved) use for diazepam includes sedation in the ICU and short-term treatment of spasticity in children with cerebral palsy. This activity will highlight the mechanism of action, adverse event profile, approved and off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, and relevant interactions of diazepam, pertinent for interprofessional team members using diazepam for any of its intended indications.

Copyright © 2024, StatPearls Publishing LLC.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Jaberpreet Dhaliwal declares no relevant financial relationships with ineligible companies.

Disclosure: Alan Rosani declares no relevant financial relationships with ineligible companies.

Disclosure: Abdolreza Saadabadi declares no relevant financial relationships with ineligible companies.

Sections

Similar articles

References

    1. Calcaterra NE, Barrow JC. Classics in chemical neuroscience: diazepam (valium). ACS Chem Neurosci. 2014 Apr 16;5(4):253-60. - PMC - PubMed
    1. Sharbaf Shoar N, Bistas KG, Saadabadi A. StatPearls [Internet] StatPearls Publishing; Treasure Island (FL): 2023. May 23, Flumazenil. - PubMed
    1. An H, Godwin J. Flumazenil in benzodiazepine overdose. CMAJ. 2016 Dec 06;188(17-18):E537. - PMC - PubMed
    1. Weintraub SJ. Diazepam in the Treatment of Moderate to Severe Alcohol Withdrawal. CNS Drugs. 2017 Feb;31(2):87-95. - PubMed
    1. Nutt DJ, Malizia AL. New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder. Br J Psychiatry. 2001 Nov;179:390-6. - PubMed

Publication types